Belantamab mafodotin is a targeted antibody therapy used to treat multiple myeloma, a type of blood cancer. It works by attaching to a specific protein on cancer cells and delivering a medication that helps destroy them.

Bortezomib is a cancer medication that belongs to a class of drugs called proteasome inhibitors. It works by blocking certain proteins that cancer cells need to grow and survive, helping to slow or stop the spread of cancer cells.

Dexamethasone is a corticosteroid medication that helps reduce inflammation and suppress the immune system. In cancer treatment, it’s often used alongside other medications to help make them more effective and manage certain side effects.

Daratumumab is a monoclonal antibody therapy that targets a specific protein found on multiple myeloma cells. It works by helping the immune system recognize and destroy cancer cells.

Multiple Myeloma – A type of blood cancer that develops in plasma cells, which are white blood cells that normally produce antibodies to help fight infections. In this condition, abnormal plasma cells multiply uncontrollably in the bone marrow, forming tumors in multiple bones throughout the body. These cancerous cells produce large amounts of abnormal proteins while preventing the production of normal, healthy blood cells. The disease can weaken bones, decrease normal blood cell production, and cause problems with kidney function. Multiple myeloma often develops slowly and may not cause symptoms in its early stages.